Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

Delayed Quote. Delayed  - 12/09 10:00:00 pm
625.21 USD   +0.93%
12/06 NASDAQ 100 MOVE : Isrg, nflx
11/16INTUITIVE SURGI : Back on a long term support level
11/16 INTUITIVE SURGI : US robotic surgery expert stresses need for early ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Intuitive Surgical, Inc. : Intuitive Surgical 1Q Profit Up 38% On Strong Revenue

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 12:14am CET

--Intuitive Surgical tops first-quarter sales and earnings estimates

--Sales of da Vinci systems, procedure growth, fuel gains

--Company raises full-year guidance for sales, procedure growth

(Updates throughout with details on results and outlook)

 
   By Jon Kamp 
   Of  
 

Intuitive Surgical Inc.'s (ISRG) first-quarter earnings rose 38%, beating Wall Street expectations behind climbing sales of the company's da Vinci robotic-surgery machines and growth in procedures.

The Sunnyvale, Calif., company boosted its full-year forecasts for both revenue and procedure growth following the strong quarterly report. Shares--which are trading near all-time high levels and have climbed 18% on the year through Tuesday's close--rose 5.8%, to $576.98 in after-hours trading.

The company's motion-capture robots, which have been heavily used for cancer-treating surgeries, such as hysterectomies and prostate removal, have remained in strong demand despite continued economic turbulence and some sluggishness in Europe. The company sold 140 machines in the recent quarter, up 20 from a year ago, and posted 29% growth in procedures.

The company saw strong growth in both general-surgery and gynecological procedures, Chief Executive Gary Guthart said on a conference call with analysts. Newly introduced da Vinci instruments also helped fuel rising sales.

Intuitive Surgical reported a profit of $143.5 million, or $3.50 a share, up from $104.1 million, or $2.59 a share, a year earlier. Revenue increased 28%, to $495.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $3.14 on revenue of $464.7 million.

Gross margin edged up to 71.9% from 71.8%.

Revenue from instruments and accessories climbed 32%, reflecting growth in da Vinci procedures and the roll-out of new products. Revenue from service deals for da Vinci machines jumped 27%. Systems revenue, reflecting newly sold machines, grew 24%.

Da Vinci systems sold for nearly $1.5 million, on average, in the recent quarter.

Despite the overall strong sales, company officials said system sales in Europe were disappointing and below historical trends. They indicated the company is working to bolster its marketing efforts there.

"European system sales reflect a challenging economic environment, however, we are also taking steps to improve our execution," Chief Financial Officer Marshall Mohr said on the conference call.

Looking ahead, Intuitive Surgical now anticipates revenue growth of 19% to 21% this year, up from the company's prior 17% to 19% forecast. The company's new guidance calls for procedure growth of 25% to 27%, up from the prior 24% to 26% target.

Analysts had forecast, on average, sales growth of about 18% this year.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

--Tess Stynes contributed to this article.

Order free Annual Report for Intuitive Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US46120E6023 or call +44 (0)208 391 6028

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL, INC.
12/06 NASDAQ 100 MOVERS : Isrg, nflx
11/17 INTUITIVE SURGICAL : $4,898 Federal Contract Awarded to Intuitive Surgical
11/16 INTUITIVE SURGICAL : US robotic surgery expert stresses need for early cancer de..
11/15 INTUITIVE SURGICAL : US robotic surgery expert stresses need for early cancer de..
11/14 INTUITIVE SURGICAL : US robotic surgery expert stresses need for early cancer de..
11/11 INTUITIVE SURGICAL : Reports New Employee Option Grants for November 2016
11/10 Intuitive Surgical Reports New Employee Option Grants for November 2016
11/10 INTUITIVE SURGICAL : Patent Application Titled "Instrument Interface" Published ..
11/09 INTUITIVE SURGICAL INC. : (ISRG) is Trading Lower on Unusual Volume for November..
11/09 INTUITIVE SURGICAL INC. : (ISRG) Falls 4.91% for November 09
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08 AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
12/09 Intuitive Surgical (ISRG) presents at Citi Global Healthcare Conference
11/22 Post-Election Losers
11/19 Are We Headed To A Trump's Imperial Circle?
11/14 Book Profits On Chemours - Cramer's Lightning Round (11/11/16)
11/13 Market Underestimating Future Growth At Mazor Robotics After Medtronic Deal
Advertisement
Financials ($)
Sales 2016 2 686 M
EBIT 2016 1 146 M
Net income 2016 732 M
Finance 2016 423 M
Yield 2016 -
P/E ratio 2016 33,31
P/E ratio 2017 30,10
EV / Sales 2016 8,86x
EV / Sales 2017 8,09x
Capitalization 24 225 M
More Financials
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICA...
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 753 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL, IN..13.42%24 225
THERMO FISHER SCIENTIF..2.51%57 441
DANAHER CORPORATION9.50%54 022
BOSTON SCIENTIFIC CORP..11.77%28 336
PHILIPS18.95%28 064
EDWARDS LIFESCIENCES C..13.07%19 322
More Results